Overview

A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Phase:
Phase 4
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
Pfizer
Treatments:
Maraviroc
Raltegravir Potassium